Department of Dermatology Archive — Page 1 of 2

Formal portrait of a bespectacled man with gray hair wearing a patterned suit jacket, white shirt, and dark patterned tie against a plain brown background.
March 12, 2024

VUMC mourns loss of former Dermatology leader George Stricklin

Modern laboratory with long workbenches, stools, overhead shelving, electrical equipment, and mobile storage cabinets.
January 29, 2024

Expanded space boosts cutting-edge research in infectious diseases and immunology

The Vanderbilt Institute for Infection, Immunology and Inflammation recently debuted state-of-the-art new facilities in Medical Center.

skin cross section
May 18, 2023

A critical skin enzyme

Detailed studies of the enzymatic properties of PNPLA1 support the requirement for this protein in skin barrier formation.

Benoit Dawant, PhD, left, Erik Tkaczyk, MD, PhD, and colleagues have developed a new way to measure human monkeypox severity.
September 22, 2022

Vanderbilt study uses AI to speed mpox drug trials

A machine learning algorithm developed by researchers at Vanderbilt performs as well as humans at identifying skin lesions in clinical photographs of people with monkeypox.

Head-and-shoulders portrait of a smiling person with short dark hair, wearing a gray collared shirt against a plain gray background. The caption identifies the person as Nicole Ward, PhD.
July 7, 2022

Ward honored by National Psoriasis Foundation

Vanderbilt’s Nicole Ward, PhD, was one of three honorees who were the focus of attention at the National Psoriasis Foundation’s 2022 Commit to Cure Gala: Celebrating Women Who Lead, held recently in Chicago.

Stylized polygonal human profile facing a network of connected hexagons containing healthcare symbols, including a cross, heart monitor, eye, syringe, pills, lungs, thermometer, stethoscope, laboratory flask, and hospital symbol, on a purple-to-blue digital background.
April 7, 2022

Computer eyeballs graft-vs-host disease

A machine learning algorithm identified areas of skin affected by chronic graft-versus-host disease on par with clinicians, opening the door to streamlining and standardizing this measure of patient response to therapy.